A focus on Swallowing, Speech, Sight · 2020. 3. 1. · Texture E Soft Diet Requires gentle...

download A focus on Swallowing, Speech, Sight · 2020. 3. 1. · Texture E Soft Diet Requires gentle chewing. Solids and thick sauces e.g. sponge pudding, fish in sauce, banana, macaroni cheese,

If you can't read please download the document

Transcript of A focus on Swallowing, Speech, Sight · 2020. 3. 1. · Texture E Soft Diet Requires gentle...

  • Supporting special populations

    with medicines adherence:

    A focus on

    Swallowing, Speech, Sight

    Nina Barnett. Consultant Pharmacist, Older People

    Medicines Use and Safety Team,

    NHS Specialist Pharmacy Services

  • Medicines and the Dysphagia Pathway

    Paresh Parmar Lead COE & Stroke Pharmacist1 Mary McFarlane Principal Speech & Language Therapist1 Danielle Thompson Senior Speech & Language Therapist1 Nina Barnett Consultant Pharmacist, Care of Older People1,2 1Northwick Park Hospital, London North West Hospitals Trust 2 Medicines Use and Safety Division, NHS Specialist Pharmacy Services

  • What is Dysphagia?

    Describes a swallowing disorder usually resulting from a neurological or physical impairment of the:

    oral (mouth),

    pharyngeal (upper throat)

    or oesophageal (lower throat) mechanisms.

  • Why is it a problem?

    Common complication of other conditions, occurring in up to

    two thirds of patients suffering stroke

    two thirds of patients with dementia,

    a quarter of patients with Chronic Obstructive Pulmonary Disease

    Associated with aspiration pneumonia and this can lead to poor functional outcomes, such as dehydration, malnutrition, increased length of hospital stay, and death

    4

  • How does dysphagia relate to medication?

    Patients with dysphagia are unable to take some oral formulations of medication.

    Medication administration errors have been found more than three times as frequently in patients with dysphagia than in those without.

    5

  • Modified fluids and diet

    While pharmacists commonly encounter solid and liquid medication, SLTs have classified food and fluid consistencies to meet swallowing needs. These can be used to support safe oral administration of medicines where simple liquid or solid medication may not be safe.

    6

  • Stage 1:

    SYRUP

    CONSISTENCY

    Stage 2:

    CUSTARD CONSISTENCY

    Stage 3

    Follow instructions as per brand of thickener selected to create appropriate consistency eg See Royal College of Speech and Language Therapists (RCSLT) RESOURCE MANUAL FOR COMMISSIONING AND PLANNING SERVICES FOR SLCN: Dysphagia 2009 (updated 2014) http://www.rcslt.org/speech_and_language_therapy/commissioning/dysphagia_manual_072014

    PUDDING

    CONSISTENCY

    http://www.rcslt.org/speech_and_language_therapy/commissioning/dysphagia_manual_072014

  • What are food textures?

    Texture D Mashed Diet Requires very little chewing eg mashed potato, kitchree, well cooked mashed fish

    Texture E Soft Diet Requires gentle chewing. Solids and thick sauces e.g. sponge pudding, fish in sauce, banana, macaroni cheese, potato, cooked carrots, tinned fruit, bread with soft filling.

    Texture B Thin blended diet Cannot be eaten with a fork. pours from a spoon rather than drops in a lump e.g. tinned tomato soup, runny yoghurt , thin custard

    Texture C

    Can be eaten with a fork. Smooth with NO LUMPS no chewing required. e.g. purees, blancmange, smooth fromage frais mousse, whipped double cream.

  • To crush or not to crush? Knowledge of food textures can allow some tablets or capsules to be administered whole, rather than crushed tablets or opened capsules, within a particular texture of food. This is always preferable from

    both legal, pharmaceutical and administration perspective.

    9

  • What about the law?

    When products are used outside their licence (e.g. crushing non-crushable tablets)

    A greater liability rests with the individual prescriber, dispenser and/or person responsible for the provision or administration of the medication

  • Minimising risk to patients and staff

    Liability can be minimized by: Clear documentation of the reason for altering the medicine Following evidence-based, safe, effective practice Obtaining consent from the patient (in England and Wales, doctors

    providing consent [in accordance with the Mental Capacity Act 2005]; in Scotland, doctors must act according to requirements of Part 5 of the Adults with Incapacity [Scotland] Act 2000)

  • Support for this process

    Supporting patients with swallowing difficulties: Medicines and dysphagia

    https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/ Barnett and Parmar. How to tailor medication formulations for patients with dysphagia 23 AUG 2016 The Pharmaceutical Journal http:// www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.article

    https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/http://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.articlehttp://www.pharmaceutical-journal.com/learning/learning-article/how-to-tailor-medication-formulations-for-patients-with-dysphagia/20201498.article

  • Flow chart for managing medicines in patients with dysphagia

  • patients with dysphagia

    Determine how the patient swallowed food and medication prior to admission

    Suggest alternative methods of administration, dosage forms, or therapeutic agents

    Prepare instructions on the medication administration that guide the patient, family member or inpatient nurse

    Document recommendations in patients notes 14

  • Helping people with communication difficulties after stroke to understand

    warfarin therapy Satinder Bhandal, Consultant Anticoagulation Pharmacist,

    Buckinghamshire Healthcare Trust and UK Clinical Pharmacy Association

    Nina Barnett Consultant pharmacist, Older People,

    Medicines Use and Safety Division, NHS Specialist Pharmacy Service

    Katrina Clarkson Principal Speech and Language Therapist,

    London North West Healthcare NHS Trust

  • What is aphasia?

    Loss or impairment of language function caused by brain damage

    Aphasia is a multimodal disorder:

    Difficulties in speaking, understanding, reading, writing

    Reduction in capacity to interpret and formulate linguistic elements (e.g. sentences, words, morphemes the smallest grammatical unit in a language)

    Murdoch (2010)

  • Who experiences aphasia?

    People who have had a

    Stroke

    Brain tumour (primary or secondary)

    Traumatic head injury

    Hypoxic brain injury

  • Who needs anticoagulation

    Stroke - AF

    Other reasons Deep Vein Thrombosis

    Pulmonary Embolus

    Mechanical heart value

    Pulmonary hypertension

    Severe cardiomyopathy

  • Which anticoagulant? Warfarin

    Advantages of warfarin Tried and tested

    well tolerated

    easy to monitor adherence

    keeps you connected with health system

    More experience in reversing and antidote available

    Disadvantages of warfarin Complex dosing regimen

    Slow onset

    Frequent monitoring trips

    Drugs and food interaction

  • What about DOACs (direct oral anticoagulants)? Advantages of DOACs

    Simple dosing regimens

    fast acting (vs warfarin can take ages to get to an effective level)

    less drug and food interaction

    less treatment burden (convenience)

    Some DOACs can be put in compliance aids

    Disavantages DOAC less well tolerated (eg one in five people stop after 2 year, rash, headache, fuzziness, GI side effect (diarrhoea can be disabling)

    Other than dabigatran, no licenced antidote

  • NPSA 2006

    Anticoagulant risk assessment

    need for doctors to give appropriate time to patients with aphasia to ensure that they

    You WILL need extra time to counsel the patient with aphasia

    So, a new tool may help........

  • What do we use now?

    Anticoagulation therapy

    Patient information booklet

    Alert card for patient

    Record of INR book

    Treatment sheets

  • What do we need to communicate effectively to patient with aphasia?

    Short message

    Clear sentences

    Easy words

    Good layout

    Diagrams and pictures

    Appropriate font

  • What did we create

    Learning event with pharmacist and speech and language therapist

    Agreed on simple, accessible, online tool which can be downloaded for local use

    Powerpoint slides using SLT guidance for presentation and pharmacist guidance for content

  • Yellow book - warfarin doses

  • Your new tablet is Warfarin

    The tablets are different strengths

    ©Bucks Healthcare & NHS Specialist Pharmacy Service 2015

  • When will you remember to take it?

    Take Warfarin once a day

    ©Bucks Healthcare & NHS Specialist Pharmacy Service 2015

  • Yellow book - INR

  • You will need regular blood tests

    It shows how much warfarin you need

    If you are ill you need an extra blood test that week

    ©Bucks Healthcare & NHS Specialist Pharmacy Service 2015

  • Yellow book dietary interactions

  • Foods

    All foods are okay

    Keep what you eat the same each week

    ©Bucks Healthcare & NHS Specialist Pharmacy Service 2015

  • Yellow book - alcohol

  • Do not drink lots of alcohol

    Keep what you drink the same each week

    ©Bucks Healthcare & NHS Specialist Pharmacy Service 2015

  • Summary for healthcare professionals

    Blood tests (INR)

    Take Warfarin every day

    No big changes to diet

    No binge alcohol

    If very ill get extra blood test that week

    Tell family and health professionals you are on Warfarin

    ©Bucks Healthcare & NHS Specialist Pharmacy Service 2015

  • Where can you get a copy?

    Tool freely available to download

    https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/

    Now includes DOACs

    ©Bucks Healthcare & NHS Specialist Pharmacy Service 2015

    https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/https://www.sps.nhs.uk/articles/warfarin-consultation-for-patients-with-aphasia/

  • Acknowledgements

    Satinder Bhandal , Consultant pharmacist Anticoagulation, Buckinghamshire Healthcare NHS. Trust

    Frances Akor, Consultant Pharmacist Anticoagulation, Imperial College Healthcare NHS Trust.

    Katrina Clarkson, Principal Speech and Language Therapist, Regional Hyperacute Rehabilitation Unit, Northwick Park Hospital,

    Clare Cahoon, Highly Specialist Speech and Language Therapist, Regional Hyperacute Rehabilitation Unit, Northwick Park Hospital,

    Nina Barnett Consultant Pharmacist, Older People, Medicines Use and Safety Division, NHS Specialist Pharmacy Service and London North West Healthcare NHS Trust

    With thanks to the UKCPA HAT group, Estelle Bloom at Making It Clear and the patients of Bucks Healthcare Trust.

    ©Bucks Healthcare and Medicines Use and Safety Division, NHS Specialist Pharmacy Service 2015

  • Medicines support for blind and partially sighted people

    Nina Barnett

    Consultant Pharmacist, Medicines Use and Safety Team, NHS Specialist Pharmacy Service

    Hugh Huddy Policy Lead,

    Royal National Institute for blind people

  • How did this come about?

    OPNet event November 2015

    Identification of gaps

    Collaborative thinking

  • What did we do?

    Recognised need to find out what is happening now

    Created a survey Feb/March 2017

    Surveyed over 200, mostly experienced hospital and community pharmacists

    How they identify people needing support

    What they currently provide

    What did we find?

  • How important is the label?

  • How did you know the patient could read the label?